FDA Investigator Vivin George

Vivin George has inspections in 3 countries as of 19 Dec 2023. Vivin George has collaborated with a combinined 3171 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
31
Last Inspection Date:
19 Dec 2023
Investigator Role:
FDA Investigator
Redica ID:
100000366
Country:
United States of America, Thailand, India
Co-Investigator(s):
Abdellah El Hajjam, Alan P Kurtzberg, Alanna Lmussawwir Bias, Alberto A Viciedo, Alice S Tsao, Alison N Stieg, Amatul H Marium, Anastasia M Shields, Anissa M Vargas, Annet R Rajan, Arduino Frankovic, Arthur G Hurst, Barbara A Gullick, Bijoy Panicher, Bijoy Panicker, Brandi L Garbutt, Brandy N Lepage, Brooke K Higgins, Camerson E Moore, CDR Ileana Barreto Pettit, Chaltu N Wakijra, Charanjeet Jassal, Charanjeet Jassal() (Cj), Charisse K Green, Chiang Syin, PhD, Christie A Garcia, Christie A Soto, Christina K Theodorou, Christos G Tsingelis, Courtney N Long, Craig D Zagata, David A Oluwo, Demitria J Argiropoulos, Demitria J Xiradakis, Deyaa Shaheen, Douglas A Campbell, Douglas G Ng, Dr. Dominick Roselle, Dr. Gopa Biswas, PhD, Dr. Robert C Horan, MD, Dr. Roslyn F Powers, Dr. Yubing Tang, Edmund F Mrak, Jr, Emest F Bizjak, Eric L Dong, BS, Erik W Koester, Erk W Koester, Felix Maldonado, Gam S Zamil, George Pyramides, Gregory Price, Gregson A Joseph, Hector J Colon Torres, Helen B Ricalde, Iram R Hassan, PhD, Jacqueline S Warner, James A Liubicich, James M Mason, James M Simpson, Jay T Wong, Jennifer C Adams, Jennifer L Bridgewater, Jennifer L Huntington, Jennifer Lalama, Jennifer M Menendez, Jessica L Pressley, Joanne E King, Jogy George, Jonah S Ufferfilge, Jonah Ufferfilge, Jonathan W Chapman, Jose Velez, Joseph W Matthews, Joshua J Silvestri, Juanita P Versace, Juklian M Badalucco, Juliana M Badalucco, Julianne C Mccullough, Junho Pak, Karen L Kosar, Karishma G Gopaul, Katherine Szestypalow, Kathleen M Jordan, Kayla V Sprague, Kenneth Gordon, Kenneth M Gordon, Kenneth Nieves, Kevin A Gonzalez, Ko U Min, Kristina L Conroy, Kwong P Lee, Larry K Hampton, Lata C Mathew, PhD, Laura D Cain, Laura Fontan, MS, Lawrence Harmon, Jr, LCDR Michael H Tollon, Lillian Mcolon Mcknight, Linda F Murphy, Linda Thai, Loretta Nemchik, Lori S Lawless, Marc S Neubauer, Marcellinus D Dordunoo, Marcus A Ray, Margaret M Doherty, Matthew A Spataro, Matthew M Henciak, Maureen A Wentzel, Melissa J Garcia, Melkamu Getie Kebtie, PhD, Michael A Charles, Michael Shanks, MS, Mindy M Chou, Miral B Patel, Misty L Treece, Mizanne E Lewis, Muralidhara B Gavini, PhD, Nadeem I Chaudhry, Nancy M Espinal, Naveen B Kanthamneni, Nebil A Oumer, Neil J Bonzagni, PhD MPH, Nicholas A Violand, Nicholas Z Lu, Nicole E Knowlton, Nikisha M Bolden, Parul M Patel, Patrick C Klotzbuecher, Paul L Bellamy, Paul Mouris, Peter S Diak, Philippa Hillyer, Rachael A Moliver, Rachael O Oyewole, Rachael Oyewole, Rachel A Peters, Rachel C Harrington, Raihan A Chowdhury, Rebecca Rodriguez, Richard K Glabach, Robert C Steyert, Robert H Wittorf, Robert J Martin, Rose Xu, Russell J Glapion, Samina S Khan, Sarah E Mcmullen, Satheesh Thomas, Sayyem H Akbar, Scott B Laufenberg, Sharon K Thoma, PharmD, Shirshendu K Deb, PhD, Simone E Pitts, Sony Mathews, Steven M Weinman, Suzanne N Vallez, Syeda N Mahazabin, Tanya R Syffrard, Tara K Carmody, Tara K Normandin, Terry Bridgewater, Thomas E Friel, Tiara Nbrown Crosen, Tonia F Bernard, Toyin B Oladimeji, Uduak M Inokon, Viviana Matta, Walter L Fava, Wanda Y Honeyblue, Xikui Chen (nmi), PhD, Yifan Wang, Yvesna C Blaise, Yvins Dezan, Zhongren Wu

Vivin George's Documents

Publish Date Document Type Title
August, 2021 FDA 483 Advanced Pharmaceutical Technology, Inc. - Form 483, 2021-08-23
November, 2022 FDA 483 Pharmaceutics International, Inc. - Form 483, 2022-11-14
March, 2023 FDA 483 Xylo Chem Industries - Form 483, 2023-03-31
December, 2021 FDA 483 ScieGen Pharmaceuticals, INC. - Form 483, 2021-12-20
February, 2022 FDA 483 Eywa Pharma Inc. - Form 483, 2022-02-02
November, 2022 EIR Pharmaceutics International, Inc. - EIR, 2022-11-14
January, 2020 FDA 483 Atlantic Biologicals - Form 483, 2020-01-14
March, 2020 FDA 483 Response CORERX, INC. - Form 483R, 2020-03-27
October, 2022 FDA 483 MANA PRODUCTS, INC. - Form 483, 2022-10-17
November, 2022 FDA 483 Pharmaceutics International, Inc. - Form 483, 2022-11-14
June, 2023 FDA 483 Amneal Pharmaceuticals of New York, LLC - Form 483, 2023-06-07
March, 2022 FDA 483 American Cleaning Solutions - Form 483, 2022-03-28
October, 2020 FDA 483 Syntec Pharma Corp. - Form 483, 2020-10-28
November, 2022 EIR Port Jervis Laboratories, Inc - EIR, 2022-11-04
November, 2022 FDA 483 Response Port Jervis Laboratories, Inc - Form 483R, 2022-11-23
June, 2021 FDA 483 Response Professional Disposables International, Inc. - Form 483R, 2021-06-23
April, 2022 FDA 483 Positive Promotions Inc. - Form 483, 2022-04-25
February, 2023 FDA 483 HomeoCare Laboratories Inc. - Form 483, 2023-02-21
December, 2022 FDA 483 Keystone Industries - Form 483, 2022-12-21
November, 2022 FDA 483 Port Jervis Laboratories, Inc - Form 483, 2022-11-04
March, 2020 EIR CORERX, INC. - EIR, 2020-03-06
March, 2020 FDA 483 CORERX, INC. - Form 483, 2020-03-06
October, 2019 FDA 483 Airgas Usa, LLC - Form 483, 2019-10-18
November, 2022 EIR Pharmaceutics International, Inc. - EIR, 2022-11-14
June, 2021 EIR Professional Disposables International, Inc. - EIR, 2021-07-30
February, 2020 FDA 483 Applied Consumer Services, Inc. - Form 483, 2020-02-21
June, 2021 FDA 483 Professional Disposables International, Inc. - Form 483, 2021-06-23
December, 2023 FDA 483 Phoenix Wipes Inc - Form 483, 2023-12-19

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more